Maternal stress in early pregnancy affects long-term health of offspring

A majority of FDA committee advisors were on the same page regarding the efficacy of an investigative treatment for an ultra-rare and fatal neurovisceral genetic

PTC Ther­a­peu­tics is stay­ing busy ahead of the Thanks­giv­ing hol­i­day. On Tues­day af­ter­noon, the com­pa­ny an­nounced that a Phase 2 tri­al eval­u­at­ing its ex­per­i­men­tal ALS